Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Design, synthesis, biological assessment, and in-Silico studies of 1,2,4-triazolo[1,5-a]pyrimidine derivatives as tubulin polymerization inhibitors
Heba S. Mohamed, Noha H. Amin, Mohammed T. El‐Saadi, et al.
Bioorganic Chemistry (2022) Vol. 121, pp. 105687-105687
Closed Access | Times Cited: 25

Showing 25 citing articles:

Recent Advances of Tubulin Inhibitors Targeting the Colchicine Binding Site for Cancer Therapy
Mohammed Hawash
Biomolecules (2022) Vol. 12, Iss. 12, pp. 1843-1843
Open Access | Times Cited: 67
Triazole-fused pyrimidines in target-based anticancer drug discovery
Xing‐Jie Dai, Lei-Peng Xue, Shi‐Kun Ji, et al.
European Journal of Medicinal Chemistry (2023) Vol. 249, pp. 115101-115101
Closed Access | Times Cited: 31
New Thiazole Carboxamide Derivatives as COX Inhibitors: Design, Synthesis, Anticancer Screening, In Silico Molecular Docking, and ADME Profile Studies
Mohammed Hawash, Nidal Jaradat, Rozan Sabobeh, et al.
ACS Omega (2023) Vol. 8, Iss. 32, pp. 29512-29526
Open Access | Times Cited: 16
Synthesis of new morpholine-benzimidazole-pyrazole hybrids as tubulin polymerization inhibiting anticancer agents
Ravikumar Reddy Sagam, Satheesh Kumar Nukala, Rajkumar Nagavath, et al.
Journal of Molecular Structure (2022) Vol. 1268, pp. 133692-133692
Closed Access | Times Cited: 24
An Update on the Recent Advances and Discovery of Novel Tubulin Colchicine Binding Inhibitors
Haoxiang Weng, Jinlong Li, Huajian Zhu, et al.
Future Medicinal Chemistry (2023) Vol. 15, Iss. 1, pp. 73-95
Open Access | Times Cited: 12
Rational design, synthesis and biological evaluation of novel 2-(substituted amino)-[1,2,4]triazolo[1,5-a]pyrimidines as novel tubulin polymerization inhibitors
Lin Chen, Tangyang Ji, Xian‐Sen Huo, et al.
European Journal of Medicinal Chemistry (2022) Vol. 244, pp. 114864-114864
Closed Access | Times Cited: 21
Synthesis of Amide Derivatives as Tubulin Polymerization Inhibiting Antiproliferative Agents
Praveen kumar Kannekanti, Satheesh Kumar Nukala, Mallikarjuna Bangaru, et al.
ChemistrySelect (2023) Vol. 8, Iss. 1
Closed Access | Times Cited: 8
Discovery of novel 2-(trifluoromethyl)quinolin-4-amine derivatives as potent antitumor agents with microtubule polymerization inhibitory activity
Kun Liu, Min Mo, Gang Yu, et al.
Bioorganic Chemistry (2023) Vol. 139, pp. 106727-106727
Closed Access | Times Cited: 8
Triazolopyrimidine Derivatives: An Updated Review on Recent Advances in Synthesis, Biological Activities and Drug Delivery Aspects
Ahmed S. Abdelkhalek, Mohamed S. Attia, Mohammad Amjad Kamal
Current Medicinal Chemistry (2023) Vol. 31, Iss. 14, pp. 1896-1919
Closed Access | Times Cited: 7
Experimental design of D-α-tocopherol polyethylene glycol 1000 succinate stabilized bile salt based Nano-vesicles for improved cytotoxicity and bioavailability of colchicine binding site inhibitor Candidates: In Vitro, in silico, and pharmacokinetic studies
Ayman Abo Elmaaty, Ahmed A. Al‐Karmalawy, Mohamed S. Nafie, et al.
International Journal of Pharmaceutics (2023) Vol. 640, pp. 122980-122980
Closed Access | Times Cited: 6
Design, Synthesis and Biological Evaluation of [1,2,4]Triazolo[1,5-a]pyrimidine Indole Derivatives against Gastric Cancer Cells MGC-803 via the Suppression of ERK Signaling Pathway
Guang-Xi Yu, Ying Hu, Weixin Zhang, et al.
Molecules (2022) Vol. 27, Iss. 15, pp. 4996-4996
Open Access | Times Cited: 10
Design, Synthesis and Biological Investigation of 2-Anilino Triazolopyrimidines as Tubulin Polymerization Inhibitors with Anticancer Activities
Romeo Romagnoli, Paola Oliva, Filippo Prencipe, et al.
Pharmaceuticals (2022) Vol. 15, Iss. 8, pp. 1031-1031
Open Access | Times Cited: 9
Benzimidazole‐Containing Compounds as Anticancer Agents
Ulviye Acar Çevik, Ayşen Işık, Betül Kaya, et al.
ChemistrySelect (2024) Vol. 9, Iss. 32
Closed Access | Times Cited: 1
An overview of the most used synthetic pathways of 1,2,4-triazolo[1,5-a]pyrimidines
Mohamed Nabil Zedan, Mai E. Shoman, Mohamed Abdel‐Aziz, et al.
Results in Chemistry (2024) Vol. 12, pp. 101903-101903
Open Access | Times Cited: 1
Two-step tandem synthesis of sugar-containing pyrimidine derivatives catalyzed by Lipozyme® TL IM in continuous-flow microreactors
Han-Jia Xie, Wen-Xuan Shao, Li‐Hua Du, et al.
RSC Advances (2024) Vol. 14, Iss. 51, pp. 38193-38199
Open Access | Times Cited: 1
Design, synthesis, and biological investigation of selective human carbonic anhydrase II, IX, and XII inhibitors using 7-aryl/heteroaryl triazolopyrimidines bearing a sulfanilamide scaffold
Romeo Romagnoli, Tiziano De Ventura, Stefano Manfredini, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry (2023) Vol. 38, Iss. 1
Open Access | Times Cited: 4
Pyrrolizine/indolizine-bearing (un)substituted isoindole moiety: design, synthesis, antiproliferative and MDR reversal activities, and in silico studies
Amr L. AbdelSamad, Mohammed T. El‐Saadi, Ahmed M. Gouda, et al.
RSC Advances (2023) Vol. 13, Iss. 44, pp. 30753-30770
Open Access | Times Cited: 2
Synthesis of Some New Coumarin-thiazolidine-2,4-dione-1,2,3-triazole Hybrids as Tubulin Targeting Anti-Lung Cancer Agents
B. Ramakrishna, B. Karthik, B. Ashok Kumar, et al.
Russian Journal of Bioorganic Chemistry (2024) Vol. 50, Iss. 2, pp. 282-292
Closed Access
Multi-component preparation of novel triazolo[1,5-a]pyrimidine derivatives under ultrasonic irradiation condition
Seyyed Jalal Roudbaraki, Omolbanin Naghizadeh-Dehno, Majid Ghashang
Results in Chemistry (2024) Vol. 7, pp. 101545-101545
Open Access
Advancements in the Synthesis of Triazolopyrimidines
S. SINGH, Raman Lakhia, Sidhant Yadav, et al.
Current Organic Chemistry (2024) Vol. 28, Iss. 20, pp. 1567-1578
Closed Access
Organo NHC catalyzed aqueous synthesis of 4β-isoxazole-podophyllotoxins: in vitro anticancer, caspase activation, tubulin polymerization inhibition and molecular docking studies
Rajkumar Nagavath, Murali Krishna Thupurani, Vinitha Badithapuram, et al.
RSC Advances (2024) Vol. 14, Iss. 33, pp. 23574-23582
Open Access
Design, synthesis, and in vitro and in vivo biological evaluation of triazolopyrimidine hybrids as multitarget directed anticancer agents
Heba Adawy, Samar S. Tawfik, Abdullah A. Elgazar, et al.
RSC Advances (2024) Vol. 14, Iss. 48, pp. 35239-35254
Open Access
The Effects of Novel Triazolopyrimidine Derivatives on H<sub>2</sub>S Production in Lung and Vascular Tonus in Aorta
Emine Nur ÖZBEK, Hüseyin İstanbullu, Umran Kızrak, et al.
Pharmacology (2023) Vol. 108, Iss. 6, pp. 530-539
Open Access | Times Cited: 1
The significance of quinazoline derivatives as potential multi-target anti-cancer agents: review article
Mostafa A. Mansour, Samar H. Abbas, Asma AboulMagd, et al.
Journal of advanced Biomedical and Pharmaceutical Sciences (2023), pp. 1-17
Open Access | Times Cited: 1
Discovery of novel tubulin CBSI (R)-9k from the indanone scaffold for the treatment of colorectal cancer
Zhipeng Huo, Delin Min, Shijie Zhang, et al.
RSC Medicinal Chemistry (2023) Vol. 14, Iss. 12, pp. 2738-2750
Open Access
Page 1

Scroll to top